Tonix Pharmaceuticals Announces Receipt Of FDA Official Minutes From Breakthrough Therapy Type B Clinical Guidance Meeting For Tonmya As Potential New Treatment For PTSD ; Says Minutes Are Consistent With Guidance Received At FDA Meeting